General Archive
-
PACE: Pathways to Antimicrobial Clinical Efficacy
PACE: Pathways to Antimicrobial Clinical Efficacy PACE is a £30 million collaborative initiative to help progress new developments to tackle…
-
LifeArc-CSO fund for Scottish translational researchers
LifeArc-CSO fund for Scottish translational researchers In association with the Chief Scientist Office (CSO) for the Scottish Government, we support…
-
LifeArc and GOSH charity fund
LifeArc and GOSH charity fund LifeArc and GOSH Charity support a joint funding scheme focused on helping GOSH researchers drive…
-
LifeArc and Action medical research fund
LifeArc and Action medical research fund Action Medical Research and LifeArc want to improve the lives of children suffering from…
-
Repurposing therapies for EB
£2.5 million to develop therapeutics for Epidermolysis Bullosa (EB) LifeArc and DEBRA Austria are partnering to commit £2.5 million to…
-
Translational rare disease centres
Translational rare disease centres With this £40 million we aim to build on the UK’s rich, rare disease research base,…
-
Muscular Dystrophy Translational Research Fund
Muscular Dystrophy Translational Research Fund The Muscular Dystrophy Translational Research Fund is a joint fund created by LifeArc and Muscular…
-
£3m fund for CF therapies
£3 million fund to accelerate development of new cystic fibrosis therapies LifeArc, as part of the CF AMR Syndicate, is…
-
Drug repurposing call to treat chronic respiratory infection
Drug repurposing call to treat chronic respiratory infection LifeArc has committed £10m to fund up to five consortia programmes that…
-
The MND collaborative partnership
The MND collaborative partnership £4.25 million partnership aimed at speeding up the development of effective MND treatments. Overview This exciting…
-
£1m Primer Fund to accelerate MND diagnosis
£1m Primer Fund to accelerate MND diagnosis The primer fund is intended to support projects which seek to develop solutions…